Table 1.

Baseline Characteristics and results of the SP efficacy study

Number of patients	29
Age, mean (SD), months	34.8 (16.6)
Sex ratio (male/female)	1.9 (19/10)
Weight, mean (SD), kg	13.0 (2.5)
Axillary temperature at admission, mean (SD), °C	37.1 (0.95)
Parasitaemia at admission, median (quartiles)	18,718 (2,800-33,300)
Day 28 PCR adjusted cure in PP analysis, n (%) Day 28 unadjusted cure in PP analysis, n (%)	12/26 (46) 10/26 (38.5)
Early treatment failures, n (%)	1 (4)
Late parasitological failures, n (%)	13 (50)
Parasite clearance time, mean (95%CI), hours	61 (45-76)
Fever clearance time, mean (95%CI), hours	22 (14-30)
Gametocyte carrier rate at admission, n (%)	2 (6)
Gametocytes carrier rate during follow-up, n (%)	22 (85)

SD: Standard Deviation, PCR: Polymerase Chain Reaction, CI: Confidence Interval, n: number of patients.